The current study showed that TMS depressed FosB and c-Fos expression in D1R+ cells of the dorsal striatum and motor cortex, suggesting a mechanism by which TMS may directly mitigate dyskinesias. This evidence concerns the gene FOS and drug-induced dyskinesia.